+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Transgene SA (TNG) - Financial and Strategic SWOT Analysis Review

  • ID: 4278367
  • SWOT Analysis
  • March 2018
  • 25 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

Transgene SA (Transgene), a subsidiary of Institut Merieux SA, is a biotechnology company that concentrates on the discovery and development of immunotherapies in the areas of cancer and infectious diseases. The company’s products include therapeutic vaccines and oncolytic viruses. It develops targeted immunotherapeutics utilizing a broad range of viral vectors. Transgene also concentrates on discovery of a novel approach to improve digestion of DNA impurities in the manufacturing of viral vectors. The company has presence in France, the US and China. Transgene is headquartered in Illkirch-Graffenstaden, France.

Transgene SA Key Recent Developments

Oct 19, 2017: Transgene: Third Quarter Marked by Progress in Clinical Development and Research
Sep 21, 2017: Transgene Launches Invir.IO, its Integrated Platform for the Next Generation of Multifunctional Oncolytic Viruses
Jun 22, 2017: Transgene Hosts Immuno-Oncology R&D Day Focused on Modulating the Tumor Micro-Environment in Paris
Apr 25, 2017: Transgene: €50.7 Million in Cash and Cash Equivalents as of March 31, 2017
Apr 19, 2017: Marie Landel and Maya Said Nominated to be Independent Members of Transgene’s Board of Directors

This comprehensive SWOT profile of Transgene SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Transgene SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 3
Section 1 - About the Company
  • Transgene SA - Key Information
  • Transgene SA - Overview
  • Transgene SA - Key Employees
  • Transgene SA - Key Employee Biographies
  • Transgene SA - Key Operational Heads
  • Transgene SA - Major Products and Services
  • Transgene SA - History
  • Transgene SA - Company Statement
  • Transgene SA - Locations And Subsidiaries
  • Transgene SA - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Transgene SA - Business Description
  • Transgene SA - Corporate Strategy
  • Transgene SA - SWOT Analysis
  • SWOT Analysis - Overview
  • Transgene SA - Strengths
  • Transgene SA - Weaknesses
  • Transgene SA - Opportunities
  • Transgene SA - Threats
  • Transgene SA - Key Competitors
Section 3 - Company Financial Performance Charts
  • Transgene SA - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Transgene SA, Key Information
  • Transgene SA, Key Ratios
  • Transgene SA, Share Data
  • Transgene SA, Major Products and Services
  • Transgene SA, History
  • Transgene SA, Key Employees
  • Transgene SA, Key Employee Biographies
  • Transgene SA, Key Operational Heads
  • Transgene SA, Other Locations
  • Transgene SA, Subsidiaries
  • Transgene SA, Key Manufacturing facilities
  • Transgene SA, Key Competitors
  • Transgene SA, SWOT Analysis
  • Transgene SA, Ratios based on current share price
  • Transgene SA, Annual Ratios
  • Transgene SA, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Transgene SA, Performance Chart
  • Transgene SA, Ratio Charts
Note: Product cover images may vary from those shown
3 of 3